Grund Nicholas
- SEC CIK
- 0001661887
In the past year, 1 open-market sale filing worth $117.9K and no purchases.
Current role at each company
- AKBA Akebia Therapeutics, Inc.Chief Commercial Officeras of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $117.9K
- 1 filing
- Net
- −$117.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Grund Nicholas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Grund NicholasChief Commercial Officer | SSale | −84.8K | $1.39 | −$117.9K | −13.1%561.8K after | 2 lots10b5-1 |
| Feb 4, 2025 (view filing) | Feb 3 | 1 day | Grund NicholasChief Commercial Officer | SSale | −55.6K | $2.10 | −$116.8K | −11.2%442.6K after | 10b5-1 |